Browse through our press and news section by category:

08.02.2013, Mainz/Mumbai (India)

SCHOTT strengthens its position in the Asian pharmaceutical market

First fully automated production line for pharmaceutical packaging sets new standards in India
Mainz/Mumbai (India), February 8, 2013 – With the opening of a high-tech facility in India, international technology group SCHOTT continues to strengthen its strategic position in the Asian pharmaceutical market. As with the existing production plant in the city of Daman, SCHOTT KAISHA, a joint venture in which SCHOTT holds a 50% stake, will run the new production facility, located in Jambusar in the western state of Gujarat. The new plant will allow SCHOTT to increase production by 50%, bringing total annual output to about two billion ampoules, vials, syringes, and cartridges. The new facility will also create 350 additional jobs.

“This investment of 20 million euros underscores SCHOTT’s long-term understanding of the strategic importance of the pharmaceutical packaging business. We are outpacing market growth in this segment,” Professor Dr.-Ing. Udo Ungeheuer, Chairman of the Management Board of SCHOTT AG, commented on the opening.

According to various studies, the Indian pharmaceutical industry is growing by 14 to 17 percent a year, primarily due to strong domestic demand from a rising Indian middle class seeking better medical care. Thanks to its strong and long-standing partnership with KAISHA, SCHOTT is in an excellent position to profit from the predicted market growth. Dr. Jürgen Sackhoff, head of the Pharmaceutical Systems Business Unit at SCHOTT, said, “Our quality-first business philosophy has always been what differentiates SCHOTT AG from other companies. In KAISHA, we found a partner in India who shares this philosophy. Together, this new facility will further enhance our ability to help the Indian pharmaceutical industry hit its growth targets.”

Fully automated production meets demanding quality standards
The new plant has 20 production lines for ampoules and 16 lines for vials – all fully automated. In addition to computer-controlled line loading using loading robots, high-performance camera systems perform quality inspections. Jambusar is the first fully automated production facility on the Indian subcontinent and meets global ISO 15378 standards. This underscores SCHOTT’s commitment to produce worldwide in compliance with the international GMP (Good Manufacturing Practice) standard, which is an important benchmark for the production of high-quality primary pharmaceutical packaging.

A path of global growth
The SCHOTT Group’s Pharmaceutical Systems business unit is on a path of global growth. The new SCHOTT Xinkang Pharmaceutical Packaging, a joint venture started last year, is also enjoying success in the important Chinese pharmaceutical market. Two facilities manufacture high-quality ampoules, vials, and cartridges for the Chinese market. In accordance with the SCHOTT philosophy of keeping production close to the customer, the Mainz-based technology group is one of the few manufacturers with a facility inside Russia. SCHOTT Pharmaceutical Systems also has production facilities in other up-and-coming pharmaceutical markets such as Brazil, Indonesia, and Argentina. SCHOTT now has 17 pharmaceutical packaging production facilities in locations around the world, including all four BRIC states.

SCHOTT is an international technology group with more than 125 years of experience in the areas of specialty glasses and materials and advanced technologies. SCHOTT ranks number one in the world with many of its products. Its core markets are the household appliance, pharmaceuticals, electronics, optics, solar power, transportation and architecture industries. The company is strongly committed to contributing to its customers’ success and making SCHOTT an important part of people’s lives with high-quality products and intelligent solutions. SCHOTT is committed to managing its business in a sustainable manner and supporting its employees, society and the environment. The SCHOTT Group maintains close proximity to its customers with manufacturing and sales units in all major markets. Its workforce of around 17,000 employees generated worldwide sales of approximately 2.9 billion euros for the 2010/2011 fiscal year. SCHOTT AG, with its headquarters in Mainz (Germany) is owned by the Carl Zeiss Foundation.

Download-Link to a ZIP file that contains this photograph in print quality:

More press photographs are available for downloading under:
Press contact
Christina Rettig
PR Manager
Hattenbergstraße 10
55122 Mainz
Phone: +49 (0)6131/66-4094
Fax: +49 (0)3641/2888-9141
Further information
Klaus Bernhard Hofmann
Vice President Corporate Public Relatio
Hattenbergstraße 10
55122 Mainz
Phone: +49 6131/66-3662
Fax: +49 3641/2888-9140
SCHOTT uses Cookies on this Website to enhance the user experience and provide the best possible Service. By continuing to browse the Website, you consent to our use of Cookies.